These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22914389)

  • 1. Postoophorectomy estrogen use and breast cancer risk.
    Nichols HB; Trentham-Dietz A; Newcomb PA; Titus LJ; Egan KM; Hampton JM; Visvanathan K
    Obstet Gynecol; 2012 Jul; 120(1):27-36. PubMed ID: 22914389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.
    Nichols HB; Trentham-Dietz A; Newcomb PA; Egan KM; Titus LJ; Hampton JM; Visvanathan K
    Breast Cancer Res; 2013; 15(5):R99. PubMed ID: 24152546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?
    Nichols HB; Visvanathan K; Newcomb PA; Hampton JM; Egan KM; Titus-Ernstoff L; Trentham-Dietz A
    Am J Epidemiol; 2011 May; 173(10):1111-20. PubMed ID: 21430192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause.
    Ferris JS; Suzuki Y; Prest MT; Chen L; Elkin EB; Hur C; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2024 Jun; 230(6):653.e1-653.e17. PubMed ID: 38365100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.
    Lovett SM; Sandler DP; O'Brien KM
    J Natl Cancer Inst; 2023 Jun; 115(6):662-670. PubMed ID: 36806439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
    Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
    JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.
    Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA
    Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
    J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
    Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
    Rebbeck TR; Levin AM; Eisen A; Snyder C; Watson P; Cannon-Albright L; Isaacs C; Olopade O; Garber JE; Godwin AK; Daly MB; Narod SA; Neuhausen SL; Lynch HT; Weber BL
    J Natl Cancer Inst; 1999 Sep; 91(17):1475-9. PubMed ID: 10469748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for in situ breast cancer.
    Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
    Kim CJ; Ryu WS; Kwak JW; Park CT; Ryoo UH
    Arch Intern Med; 1996 Mar; 156(5):500-4. PubMed ID: 8604955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
    Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
    Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontraceptive hormone use and risk of breast cancer.
    Yang CP; Daling JR; Band PR; Gallagher RP; White E; Weiss NS
    Cancer Causes Control; 1992 Sep; 3(5):475-9. PubMed ID: 1525328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual factors in relation to breast cancer risk.
    Titus-Ernstoff L; Longnecker MP; Newcomb PA; Dain B; Greenberg ER; Mittendorf R; Stampfer M; Willett W
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.